Assyro AI

Orange Book product · Generic (ANDA)

SACUBITRIL AND VALSARTAN

SACUBITRIL; VALSARTAN

Generic (ANDA)ANDA 213611TE ABRX NOVUGEN PHARMA SDN
View SACUBITRIL; VALSARTAN familyOpen on FDA Orange Book

At a glance

Jul 16, 2025

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 16, 2025

    11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SACUBITRIL; VALSARTAN

Strength

24MG;26MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 213611

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SACUBITRIL; VALSARTAN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo